MADRIGAL PHARMACEUTICALS, INC. (NASDAQ:MDGL) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event.
MADRIGAL PHARMACEUTICALS, INC.'s stock currently trades at $489.31 with a market capitalization of $12.7B. The Healthcare company's stock moved following the disclosure.